Citicoline: Update on a promising and widely available agent for neuroprotection and neurorepair

Reviews in Neurological Diseases

Volumn 5, Issue 4, 2008, Pages 167-177

  Saver, Jeffrey L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Citicoline; Intracerebral hemorrhage; Ischemic stroke; Neuroplasticity; Neuroprotection

Indexed keywords

CITICOLINE; PLACEBO;

CELL GROWTH; CELL REGENERATION; CLINICAL TRIAL; DIET SUPPLEMENTATION; DRUG EFFICACY; DRUG MECHANISM; DRUG STRUCTURE; GASTROINTESTINAL SYMPTOM; HUMAN; IRRITABILITY; NEUROIMAGING; NEUROLOGIC DISEASE; NEUROPROTECTION; NEUROTRANSMISSION; NONHUMAN; RESTLESSNESS; REVIEW; SIDE EFFECT; STROKE;

ACETYLCHOLINE; ANIMALS; CELL MEMBRANE; CLINICAL TRIALS AS TOPIC; COGNITION DISORDERS; CRANIOCEREBRAL TRAUMA; CYTIDINE DIPHOSPHATE CHOLINE; DOPAMINE; FATTY ACIDS, NONESTERIFIED; GLAUCOMA; HUMANS; META-ANALYSIS AS TOPIC; NERVE REGENERATION; NEURONS; NEUROPROTECTIVE AGENTS; OPTIC NEUROPATHY, ISCHEMIC; PARKINSON DISEASE; PHOSPHOLIPIDS; STROKE;

EID: 58149088543     PISSN: 15452913     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (31)

1. Secades JJ, Lorenzo JL. Citicoline: pharmacological and clinical review, 2006 update. Methods Find Exp Clin Pharmacol. 2006;28(suppl B):1-56.
2. Conant R, Schauss AG. Therapeutic applications of citicoline for stroke and cognitive dysfunction in the elderly: a review of the literature. Altern Med Rev. 2004;9:17-31.
3. Davalos A. Citicoline. Int J Stroke. 2008;3(suppl 1):440.
4. Boismare F, Le Poncin M, Lefrancois J, Lecordier JC. Action of cytidine diphosphocholine on functional and hemodynamic effects of cerebral ischemia in cats. Pharmacology. 1978;17:15-20.
5. Dorman R, Dabrowiecki Z, DeMedio G, et al. Control of lipid metabolism in ischemic brain by CDPamines. In: Horrocks L, Ansell G, Porcellati G, Kanfer J, eds. Phospholipids in the Nervous System: Metabolism. New York: Raven Press; 1982:123-135.
6. Krupinski J, Ferrer I, Barrachina M, et al. CDP-choline reduces pro-caspase and cleaved caspase-3 expression, nuclear DNA fragmentation, and specific PARP-cleaved products of caspase activation following middle cerebral artery occlusion in the rat. Neuropharmacology. 2002;42:846-854.
7. Adibhatla RM, Hatcher JF, Larsen EC, et al. CDP-choline significantly restores phosphatidylcholine levels by differentially affecting phospholipase A2 and CTP: phosphocholine cytidylyltransferase after stroke. J Biol Chem. 2006;281:6718-6725.
8. Hurtado O, Pradillo JM, Fernandez-Lopez D, et al. Delayed post-ischemic administration of CDP-choline increases EAAT2 association to lipid rafts and affords neuroprotection in experimental stroke. Neurobiol Dis. 2008;29:123-131.
9. Hurtado O, Cardenas A, Pradillo JM, et al. A chronic treatment with CDP-choline improves functional recovery and increases neuronal plasticity after experimental stroke. Neurobiol Dis. 2007;26:105-111.
10. Shuaib A, Yang Y, Li Q. Evaluating the efficacy of citicoline in embolic ischemic stroke in rats: neuroprotective effects when used alone or in combination with urokinase. Exp Neurol. 2000;161:733-739.
11. Alonso de Lecinana M, Gutierrez M, Roda JM, et al. Effect of combined therapy with thrombolysis and citicoline in a rat model of embolic stroke. J Neurol Sci. 2006;247:121-129.
12. Onal MZ, Li F, Tatlisumak T, et al. Synergistic effects of citicoline and MK-801 in temporary experimental focal ischemia in rats. Stroke. 1997;28:1060-1065.
13. Ataus SA, Onal MZ, Ozdem SS, et al. The effects of citicoline and lamotrigine alone and in combination following permanent middle cerebral artery occlusion in rats. Int J Neurosci. 2004;114:183-196.
14. Sobrado M, Lopez MG, Carceller F, et al. Combined nimodipine and citicoline reduce infarct size, attenuate apoptosis and increase bcl-2 expression after focal cerebral ischemia. Neuroscience. 2003;118:107-113.
15. Schabitz WR, Li F, Irie K, et al. Synergistic effects of a combination of low-dose basic fibroblast growth factor and citicoline after temporary experimental focal ischemia. Stroke. 1999;30:427-431; discussion 431-422.
16. Warach S, Pettigrew LC, Dashe JF, et al. Effect of citicoline on ischemic lesions as measured by diffusion-weighted magnetic resonance imaging. Citicoline 010 Investigators. Ann Neurol. 2000;48:713-722.
17. Tazaki Y, Sakai F, Otomo E, et al. Treatment of acute cerebral infarction with a choline precursor in a multicenter double-blind placebo-controlled study. Stroke. 1988;19:211-216.
18. Clark WM, Warach SJ, Pettigrew LC, et al. A randomized dose-response trial of citicoline in acute ischemic stroke patients. Citicoline Stroke Study Group. Neurology. 1997;49:671-678.
19. Clark WM, Williams BJ, Selzer KA, et al. A randomized efficacy trial of citicoline in patients with acute ischemic stroke. Stroke. 1999;30:2592-2597.
20. Clark WM, Wechsler LR, Sabounjian LA, Schwiderski UE. A phase III randomized efficacy trial of 2000 mg citicoline in acute ischemic stroke patients. Neurology. 2001;57:1595-1602.
21. Secades JJ, Alvarez-Sabin J, Rubio F, et al. Citicoline in intracerebral haemorrhage: a double-blind, randomized, placebo-controlled, multicentre pilot study. Cerebrovasc Dis. 2006;21:380-385.
22. Chua R. Role of intravenous citicoline for supratentorial hemorrhage. Cerebrovasc Dis. 2007;23(suppl 2):73.
23. Saver J, Wilterdink J. Choline precursors in acute and subacute human stroke: a meta-analysis [abstract]. Stroke 2002;33:353.
24. Davalos A, Castillo J, Alvarez-Sabin J, et al. Oral citicoline in acute ischemic stroke: an individual patient data pooling analysis of clinical trials. Stroke. 2002;33:2850-2857.
25. Kwiatkowski TG, Libman RB, Frankel M, et al. Effects of tissue plasminogen activator for acute ischemic stroke at one year. National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study Group. N Engl J Med. 1999;340:1781-1787.
26. Fioravanti M, Yanagi M. Cytidinediphosphocholine (CDP-choline) for cognitive and behavioural disturbances associated with chronic cerebral disorders in the elderly. Cochrane Database Syst Rev. 2005:CD000269.
27. Parisi V, Coppola G, Ziccardi L, et al. Cytidine-5′- diphosphocholine (Citicoline): a pilot study in patients with non-arteritic ischaemic optic neuropathy. Eur J Neurol. 2008;15:465-474.
28. Babb SM, Wald LL, Cohen BM, et al. Chronic citicoline increases phosphodiesters in the brains of healthy older subjects: an in vivo phosphorus magnetic resonance spectroscopy study. Psychopharmacology (Berl). 2002;161:248-254.
29. Boudouresques AB, Michel B. Therapeutic conduct in light of a cerebral vascular accident and the use of CDP-choline [in French]. Presented at: International Symposium: Brain Suffering and Precursors of Phospholipids. Paris; January 18, 1980:109-121.
30. Goas JY, Bastard J, Missoum A. Results after 90 days of stroke treatment with CDP choline, concerning a double blind trial [in French]. Presented at: International Symposium: Brain Suffering and Precursors of Phospholipids. Paris; January 18, 1980:123-128.
31. Corso EA, Arena M, Ventimiglia A, et al. CDP choline in cerebral vasculopathy: clinical evaluation and instrumental semeiology [in Italian]. Clin Ter. 1982;102:379-386.